Table 1.
Study | Country | Case group | Control group* | NOS | |||
n | Age, M (range) | Men (%) | n | Type | |||
Almasi et al (2009)e1 | Hungary | 194 | 43 (30–62) | 80.9 | 194 | Living† | 5 |
Altindag et al (2005)e2 | Turkey | 26 | 24 (12–62) | 15.4 | 25 | Living | 9 |
Anton-San-Martin et al (2013)e3 | Spain | 40 | 56 (19–90) | 67.5 | 80 | Living | 7 |
Appleby et al (1999)e4 | England | 84 | 27 (13–34) | 81.0 | 64 | Living | 6 |
Arafat et al (2021)e5‡ | Bangladesh | 100 | 26 (9–75) | 49.0 | 100 | Living | 7 |
Beautrais (2001)e6‡ | New Zealand | 202 | 37 (14–88) | 77.7 | 984 | Living | 7 |
Chachamovich et al (2015)e7 | Canada | 120 | 23 | 82.5 | 120 | Living | 4 |
Chen et al (2006)e8‡ | China | 150 | 39 (15–59) | 64.0 | 150 | Living | 7 |
Cheng et al (2000)e9‡ | Taiwan | 113 | NR | 61.5 | 226 | Living | 8 |
de la Vega Sanchez et al (2020)e10 | Spain | 192 | 54 | 100 | 81 | Deceased | 4 |
De Leo et al (2013)e11‡ | Australia | 261 | ≥35 | 75.1 | 182 | Deceased | 6 |
Foster et al (1999)e12 | Ireland | 117 | 16–76 | 79.5 | 117 | Living | 7 |
Gururaj et al (2004)e13 | India | 269 | 75% 16–49 | 64.3 | 269 | Living† | 7 |
Jia et al (2014)e14‡ | China | 200 | 61 (11–93) | 57.5 | 200 | Living | 7 |
Jollant et al (2014)e15 | Philippines | 15 | 15–64 | 73.3 | 30 | Living | 5 |
Khan et al (2008)e16 | Pakistan | 100 | NR | 83.0 | 100 | Living | 7 |
Kim et al (2003)e17‡ | Canada | 115 | 29 (18–65) | 100 | 82 | Living | 8 |
Kodaka et al (2017)e18‡ | Japan | 102 | ≥20 | 69.6 | 334 | Living | 7 |
Kolves et al (2006)e19‡ | Estonia | 427 | 48 | 80.3 | 427 | Living† | 7 |
Kurihara et al (2009)e20 | Indonesia | 60 | 41 (13–87) | 63.3 | 120 | Living | 9 |
Manoranjitham et al (2010)e21 | India | 100 | 42 | 59.0 | 100 | Living | 6 |
Martiello et al (2019)e22 | Italy | 91 | ≥25 | 80.2 | 270 | Living | 7 |
Morales & Martinez (2010)e23 | Colombia | 101 | 28 | 69.3 | 112 | Deceased | 7 |
Nicolas et al (2016)e24‡ | Canada | 42 | 37 | 50.0 | 42 | Living | 5 |
Overholser et al (2012)e25 | United States | 148 | 47 | 78.4 | 257 | Deceased | 4 |
Owens et al (2003)e26 | England | 100 | ≥18 | 67.0 | 100 | Living | 6 |
Page et al (2014)e27 | Australia | 84 | 18–34 | 84.5 | 250 | Living | 7 |
Palacio et al (2007)e28‡ | Colombia | 108 | 29 (19–43) | 80.6 | 108 | Deceased | 6 |
Politakis et al (2017)e29 | Slovenia | 90 | 49 | 70.0 | 90 | Living | 4 |
Rasouli et al (2019)e30 | Iran | 40 | 39 (19–75) | 80.0 | 40 | Living† | 7 |
Ross et al (2017)e31 | Australia | 126 | 25–44 | 100 | 68 | Deceased | 6 |
Schneider et al (2006)e32‡ | Germany | 163 | 50 | 64.4 | 396 | Living† | 6 |
Tong & Phillips (2010)e33‡ | China | 895 | 42 (12–94) | 50.7 | 701 | Deceased | 5 |
Vijayakumar & Rajkumar (1999)e34 | India | 100 | ≥15 | 55.0 | 100 | Living | 7 |
Zhang et al (2004)e35‡ | China | 66 | 46 | 72.7 | 66 | Living | 5 |
Zhang et al 2010e36‡ | China | 392 | 27 (15–34) | 54.6 | 416 | Living | 7 |
Zonda (2006)e37 | Hungary | 100 | 52 | 67.0 | 100 | Deceased | 7 |
Note. References are provided in online supplemental table S3.
*Matched with the case group for age and sex in all but five studies.e6,e10,e11,e25,e33
†Control subjects acted as their own informants.
‡Multiple publications for this study.
NOS, Newcastle-Ottawa Scale score; NR, not reported.